Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/07
End: 10/31/10
Due: 10/31/11
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer | NCT00427245 | Anglo Celtic Cooperative Oncology Group | user2@example.com | None | 2004-08-31 | - | - | - | - | 2025-07-14 |
| Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer | NCT00030758 | Anglo Celtic Cooperative Oncology Group | user2@example.com | None | 2001-10-31 | - | - | - | - | 2025-07-14 |
| Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer | NCT00639366 | Anglo Celtic Cooperative Oncology Group | user2@example.com | None | 2007-02-28 | 2010-10-31 | 2011-10-31 | - | - | 2025-07-14 |